Close Menu

single molecule array

Quanterix is now "shifting from an R&D phase to a commercial phase" as it prepares to launch its Simoa platform next year.

By Adam Bonislawski
Scientists at the Forsyth Institute, Beth Israel Deaconess Medical Center, and biomarker firm Quanterix announced this week a collaboration to evaluate protein biomarkers for tuberculosis.

This article has been updated to clarify that the Forsyth Institute was the recipient of the Gates Foundation grant.
By a GenomeWeb staff reporter

Quanterix said this week that it has received an investment of an undisclosed amount from In-Q-Tel, a non-profit investment firm that delivers technology to the US intelligence community.

Pages

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.